whitepaper (final) on the benefits of ozonator ng technology

A cleaner, safer environment

www.ozonatorindustries.com

[Type text]

WHITEPAPER ON THE

OZONATOR - NG TECHNOLOGY!

MEDICAL & BIO-HAZARDOUS WASTE TREATMENT BY OZONE!

THE ALTERNATIVEMEDICAL WASTE TREATMENT TECHNOLOGY

TO INCINERATION/ AUTOCLAVE/ MICROWAVE/ CHEMICAL!

Benefits of OZONATOR NG Technology for the Treatment and Sterilization of Medical and Bio-Hazard

Waste

Owner/ Founder: Jeffrey C Block Cell: +27 71 5200707 Fax +27 865418000Email: [email protected] Website. www.ozonatorza.co.za

PO Box 887, Strand, Cape Town. South Africa 7139

http://www.ozonatorza.co.za/

mailto:[email protected]



[Type text]

OZONATOR Industries Limited white paper outlines the environmental benefits of ozone based technology over incineration, autoclaves, microwave and other technologies for the treatment of regulated medical waste and bio-hazard waste.

OZONATOR Industries Ltd. is the world-wide manufacturer of the OZONATOR NG-3000 medical and bio-hazard waste treatment technology – with zero emissions.

OZONATOR INDUSTRIES LTD.

OZONATOR Industries Limited is located and based in Regina, Saskatchewan Canada and is a privately owned company that specializes in the research, design and development of ozone based technologies for both sterilization and sanitation.

The OZONATOR NG technology is a revolutionary advancement in waste treatment technology that is a sustainable alternative to incineration, chemical, autoclave and heat treatment of bio-hazard waste. Ozone is







[Type text]

produced on board the OZONATOR unit from oxygen extracted from ambient air to treat the waste at 6 log 10 reductions (99.9999%) sterilization. Any excess ozone from the treatment process is converted back to oxygen resulting in zero emission into the environment.

The patented OZONATOR technology holds promise for medical facilities and communities around the

globe. No longer do they need to be concerned that the handling of their bio-hazardous waste is

harming theirWorkers, their communities and the environment, nor do they need to be concerned with the risk of rising costs demanded by the bio-hazardous waste service providers. The OZONATOR is an immediate, on-site, cost effective and environmentally sustainable method of dealing with medical and bio-hazardous waste.

The OZONATOR technology is just the first of many technologies that Ozonator Industries will be commercializing over the next few years, all of which will prove to be both revolutionary in design and global in need.

OZONATOR INDUSTRY ZA (PTY) LTD. HOLDS EXCLUSIVITY TO ALL PRODUCTS OF THE OZONATOR NG BRAND IN AFRICA!

TECHNOLOGY DESCRIPTION:

The OZONATOR is designed to treat bio-hazardous and regulated medical wastes using ozone as the sterilizing agent. The treatment can be carried out on-site as well as off-site.

The OZONATOR technology is the new NG-3000 model capable of processing up to 400 kg of waste every twenty minutes (1200 kg per hour) and can operate on a continuous basis 24 hours per day – 7 days per week with about one hour per week for service and cleaning. The waste is shredded with up to 90% reduction in volume and treated with a high concentration of ozone (sterilized) and then compacted into a stainless steel transport bin for disposal at landfill as general waste (daily cover) or the treated waste can be used as fuel in a WTE (waste-to-energy) facility. (CV 36.4 MJ/kg)

The OZONATOR NG-3000 technology has “zero emissions”. The Ozone is produced from oxygen that is extracted from the ambient air and any residual ozone is converted back to oxygen.

Waste is treated at room temperature. There is no heat, no steam, no chemicals, no fuels, no residue and no by-product of the process.

The process (NG-3000 technology) requires electrical power at less than 12 kWh per cycle, a small amount of water (0.5 liters) and compressed air to sterilize up to 400 kg of biohazard waste per twenty minute cycle.







[Type text]

Operating cost is less than USD $0,004/ R0.25 per kilogram of waste treated!

Ozone treatment is the most cost effective and sustainable technology available and has zero emissions.

OZONE:

OZONE is a form of oxygen, consisting of three oxygen molecules (O3). Unlike diatomic oxygen (O2 the breathable oxygen present in the atmosphere), ozone is very unstable, and decays back into O2 within about30 minutes under normal atmospheric conditions.

OZONE is a powerful oxidizing agent. OZONE is effective to kill essentially all pathogens including bacteria, fungi, viruses, as well as prions. OZONE is of particular value as a disinfectant, as it is able to promote the oxidation of carbon-carbon double bonds (C=C). This type of bond is found in many biological molecules, and in other types of organic compounds, most notably pharmaceuticals.

• Ozone in use as a sterilizing agent for over 100 years• Proven operational safety and efficacy• Kills all known pathogens• Does not promote resistance• Leaves no residues• Nature’s most effective and efficient bactericides and fungicides• OZONATOR technology is certified 6 log10 reduction using ozone• Ozone converts back to oxygen naturally• Ozone is 1.66 times heavier than air• Standard biological indicators used for regular testing and verification

Ozone has the ability to diffuse rapidly through cell walls and interfere with cellular respiration process. In addition, decomposition of ozone in water or in contact with water vapour generates hydroxyl radicals (•OH), which may also play an important role in disinfection by ozone. This is because OH-radical is one of the most powerful oxidants and reacts indiscriminately with nearly all organic compounds.

The Ozonator operates under atmospheric pressure and at room temperature. The equipment shreds biomedical waste to small pieces, loads it into the treatment chamber, and treats it with ozone for a period of900 seconds. The concentration of ozone in the treatment chamber is between 5500 and 9500 parts per million (ppm).

Additionally, water vapor in the presence of ozone will form hydroxyl radicals to support the sterilization of the waste, specifically destroying oxidative cells and red blood cells.







[Type text]

The efficacy testing results of medical waste treatment by the Ozonator using Bacillus atrophaeus as a surrogate test organism were found to support the performance claim.

The waste is finely shredded and treated with ozone. The volume of waste is reduced by up to 90% The finished product is not discernible as medical or bio-hazardous waste. The waste is safe and ready for landfill. Treated waste makes ideal daily cover at landfill sites

The treated waste can be sent directly to landfill as general waste or used as fuel in a waste to energy facilities and has a calorific value of 36.4 MJ/kg as measured at Cardiff University in Wales.

APPLICATION FOR THE OZONATOR TECHNOLOGY:

• Hospitals• Nursing Homes• Universities• Laboratories• Medical & Dental Facilities• Research Facilities• Cruise Ships and Vessels• Resorts and Hotels• Remote Communities• Transfer Stations MSW• Airports & Terminals• Military Facilities• Correctional Facilities• Industry & Commercial Operations• Documents and General waste• Border protection (international and quarantined waste)

The OZONATOR uses a small amount of water (2 liters per hour), electricity (36 kWh per hour) and a unique patented technology using ozone to sterilize up to 400 kg [880 lbs.] of bio-hazard waste per cycle and up to 1200 kg [2640 lbs.] per hour. The OZONATOR can be operated 24 hours per day and seven days per week. The OZONATOR is designed for a twenty plus (20+) year service life resulting in a very low life-cycle cost.







[Type text]

The OZONATOR is simple to install, effortless to operate, easy to maintain, cost effective, designed for a twenty plus (20+) year service life, has remote monitoring capabilities through internet connection, computer tracking of waste capability, touch screen operation and is the only technology available that sterilizes the shredder and receiving hopper every cycle.

WASTE COMPATIBILITY WITH TREATMENT PROCESS:

The OZONATOR technology is compatible with the following types of waste:

Cultures and stocks of infectious agents and associated biologicalsLiquid human and animal waste, including blood and blood products and body fluidsPathological WasteContaminated waste from animalsSharps

General bio-hazardous wasteQuarantined waste (international waste) airportsGeneral waste (i.e. hospital ward or kitchen waste, etc.)

Note:

The OZONATOR is the on l y technology approved for the processing of anatomical waste.The OZONATOR does not create offensive odours or any by-products during the processing of waste. The OZONATOR sterilizes the shredder and receiving hopper every cycle.

ENVIRONMENT CANADA VERIFICATION OF THE OZONATOR TECHNOLOGY.

The OZONATOR TM technology recently underwent an extensive review and analysis by the ETV CanadaProgram.

The Canadian Environmental Technology Verification (ETV) Program is delivered by ETV Canada under a license agreement from Environment Canada. The Canadian ETV Program is designed to support Canada’s environment industry by providing credible and independent verification of technology performance claims.







[Type text]

Dr. Colin Rasmussen has a Ph.D. in Cell Biology from Baylor College of Medicine at the Texas Medical Center in Houston, Texas. From 1991 – 1997, he was an Associate Professor of Cell Biology at the University of Alberta, and for part of that time Director of the NCI Molecular Mechanisms in Growth Control Research Group.

From 1997 – 2003, he was an Associate Professor of Anatomy & Cell Biology at the University of Saskatchewan. He has extensive experience in biochemistry, molecular biology and cellular biology, as well as experience in immunology and microbiology. Dr. Rasmussen is also a patent lawyer and provided both consulting services for the design of the OZONATOR technology and prepared the patent documents and registration.

Environmental Technology Verification Program – ETV Canada - 2070 Hadwen Road, Mississauga, Ontario

OZONATOR NG-1000 PERFORMANCE CLAIM EVALUATION - ETV Certification

The efficacy of the Ozonator NG-1000 for treating bio-hazardous and regulated medical wastes has been tested employing a surrogate bacterium, Bacillus subtilus (B.atrophaeus), and a surrogate waste composed of10% glass/sharp, 30% plastic, 20% paper, 20% cloth/woven materials, and 20% liquids/organics. The waste was shredded, loaded into the treatment chamber and ozonated for 900 seconds (or 15 minutes).

The ozone concentration in the treatment chamber ranged from 4000 to 8000 ppm; temperature ranged between 17 to 24 °C; and humidity was between 70 and 100 per cent. Test results show the Ozonator NG-1000 was able to kill B.subtilus and reduce its viability by at least 6 orders of magnitude or 6 log10 (99.9999 %) reduction.

GLOBE Performance Solutions provides third-party performance measurement and verification services based on the proposed international protocol for environmental technology verification currently being considered by the International Working Group on Environmental Technology Verification.







[Type text]



[Type text]

THE FIRST INSTALLATION:

In January of 2008, Ozonator Industries announced the sale of its first OZONATOR NG-1000 to the U n i t e d States. This first NG-1000 unit was installed at Union Hospital in Terre Haute, Indiana - USA.

Union Hospital now serves as a model of how a facility can take control and ownership of the issues associated with its bio-hazardous waste management and can turn what was an environmental concern into an opportunity for bottom-line cost-savings. Since installing their NG-1000, Union Hospital has experienced significant economic savings with regard to the costs associated with the handling of their bio-hazardous waste stream.

The Union Hospital has reported cost savings exceeding 60 % in medical waste management using the OZONATOR NG-1000 technology.

Union Hospital

7th Street Entrance

1606 N. 7th St. Terre Haute, IN

47804 (812)238-7000



[Type text]



[Type text]

In July of 2012, OZONATOR Industries introduced the new NG-3000 model with a 50% increase in capacity.

All OZONATOR units and models are available in 60 Hz and 50 Hz configurations for worldwide distribution.

The OZONATOR NG-3000 is available in standard (MS) or premium stainless steel (SS) models.



[Type text]

2014 North American Biohazardous Waste Treatment Technology InnovationLeadership Award

BEST PRACTICES RESEARCH

Frost & Sullivan’s Global Research PlatformFrost & Sullivan is in its 50th year in business with a global research organization of 1,800 analysts and consultants who monitor more than 300 industries and 250,000 companies. The company’s research philosophy originates with the CEO’s360-Degree Perspective™, which serves as the foundation of its TEAM Research™ methodology. This unique approach enables us to determine how best-in-class companies worldwide manage growth, innovation and leadership. Based on the findings of this Best Practices research, Frost & Sullivan is proud to present the 2014 North American Technology Innovation Leadership Award in Biohazardous Waste Treatment to Ozonator Industries.

Significance of the Technology Innovation Leadership AwardKey Industry Challenges Addressed by Superior OZONATOR TechnologyBiohazardous wastes need to be handled, treated, and disposed of in a very safe manner in order to avoid possible hazards. Frost & Sullivan notes that this waste clearly requires an efficient, eco- friendly and cost-effective treatment technology. Treating biohazardous waste using ozone is considered to be the safest approach among all available alternatives. However, before the ozone- based biohazardous waste treatment technology can be adopted on a wider scale commercially, Frost & Sullivan points out the important industry challenges below.

Lack of treatment efficiency:Existing biohazardous waste treatment technologies perform rather inefficiently, and after treatment, large amounts of residue or by-product are produced, which need to be safely disposed of in a landfill. However, as land availability for landfills is decreasing rapidly, an efficient technology that can maximize the volume reduction of biohazardous waste needs to be identified.

High energy requirement and operating cost:Commonly adopted biohazardous waste treatment technologies, such as incineration, autoclaving, and so on, are highly energy-intensive. The high-energy requirement increases the cost of operation quite significantly. Moreover, in order to address the challenge of global energy scarcity, a



[Type text]

reduction in energy requirements is necessary to establish the future sustainability of a biohazardous waste treatment technology.

Lack of sustainability:Frost & Sullivan points out that the existing biohazardous waste treatment technologies are found to be non-sustainable from an environmental point of view. As most of these technologies work in a higher temperature range, and various waste gases are generated and emitted into the atmosphere from these systems, the sustainability of these technologies is often questionable. Moreover, many chemical treatment technologies involve the usage of toxic and hazardous chemicals, which require sufficient treatment before they can be finally discharged into the environment.

Frost & Sullivan firmly believes that the biohazardous waste treatment technology developed by Ozonator Industries has successfully addressed the above challenges. This technology employs the usage of ozone to safely treat biohazardous waste in an energy efficient and cost-effective manner. This zero-emission system completely eliminates the requirement of by-product or residue disposal. As such, the challenge of land availability and environmental sustainability is efficiently addressed by this innovation.

Key Benchmarking Criteria for Technology Innovation Leadership AwardFor the Technology Innovation Leadership Award, the following criteria were used to benchmarkOzonator Industries' performance against key competitors:

• Uniqueness of Technology• Impact on New Products/Applications• Impact on Functionality• Impact on Customer Value• Relevance of Innovation to Industry

Decision Support Matrix and Measurement CriteriaTo support its evaluation of best practices across multiple business performance categories, Frost & Sullivan employs a customized Decision Support Matrix (DSM). The DSM is an analytical tool that compares companies’ performance relative to each other with an integration of quantitative and qualitative metrics. The DSM features criteria unique to each Award category and ranks importance by assigning weights to each criterion. The relative weighting reflects current market conditions and illustrates the associated importance of each criterion according to Frost & Sullivan. Fundamentally, each DSM is distinct for each market and Award category. The DSM allows our research and



[Type text]

consulting teams to objectively analyze each company's performance on each criterion relative to its top competitors and assign performance ratings on that basis. The DSM follows a 10-point scale that allows for nuances in performance evaluation; ratings guidelines are shown in Chart 1.

Chart 1: Performance-Based Ratings for Decision Support Matrix This exercise encompasses all criteria, leading to a weighted average ranking of each company. Researchers can then easily identify the company with the highest ranking. As a final step, the research team confirms the veracity of the model by ensuring that small changes to the ratings for a specific criterion do not lead to a significant change in the overall relative rankings of the companies.

Best Practice Award Analysis for Ozonator IndustriesThe Decision Support Matrix, shown in Chart 3, illustrates the relative importance of each criterion for the Technology Innovation Leadership Award and the ratings for each company under evaluation. To remain unbiased while also protecting the interests of the other organizations reviewed, we have chosen to refer to the other key players as Competitor 1 and Competitor 2.



[Type text]

Criterion 1: Uniqueness of TechnologyThe biohazardous waste treatment technology developed by Ozonator Industries extracts oxygen from the ambient air and converts it to ozone with the help of a plasma ozone generator. This ozone is used to treat biohazardous waste in a very safe manner. This treatment is done at room temperature, and no steam, heat, or by-products are produced from this system during the operation. After the treatment, the residual ozone is automatically converted back into oxygen.Frost & Sullivan appreciates the fact that this system is a completely zero-emission system. With thehelp of this technology, more than a 90% volume reduction of biohazardous waste can be achieved. Moreover, this efficient technology can easily treat any kind of biohazardous waste (except large metal wastes).

Criterion 2: Impact on New Products/ApplicationsOzonator’s biohazardous waste treatment system is quite efficient in operation and can easily treat approximately 1200 kgs of biohazardous waste per hour. This system is a standalone system with a considerably smaller footprint and consists of no boiler or stacks, which offers increased ease of operation. This system can efficiently run around the clock, without any skilled labor or maintenance. The OZONATOR technology is ideally suited for quarantined waste from airports, border security and prisons, etc.

Criterion 3: Impact on FunctionalityOzonator’s biohazardous waste treatment system is extremely energy efficient and requires only 36 kWh of electricity to treat 1,200 kgs of biohazardous waste. The energy requirement is significantly less than that of the other existing biohazardous waste treatment systems available in the market. This system is completely automated, and system performance is automatically monitored. It is simple to operate, requiring very little training for operation.Moreover, as this system uses no chemicals, and there are no emissions, it can be consideredextremely safe and environmentally sustainable.

Criterion 4: Impact on Customer ValueThe operating cost of Ozonator’s biohazardous waste treatment system only involves the cost of energy. The energy cost of this system is approximately $3.60 per hour of operation, which Frost & Sullivan independent analysis confirms is considerably lower than that of the other competing technologies. Moreover, due to the high-volume reduction efficiency, the amount of residue



[Type text]

produced after treatment is very little. This residue can be further used as a raw material for energy production through a waste-gasifier. The company offers this system in different sizes and capacities. As such, customers have the freedom to select a system capacity according to their requirements. A minimum requirement of skilled labor and maintenance ensures the considerably low operational and maintenance costs of this system.

Criterion 5: Relevance of Innovation to IndustryThis biohazardous waste treatment technology has already been patented by Ozonator Industries. The company has also developed a presence in various important global markets. Moreover, through its continuous in-house research and development, the company is continually improving the system’s performance. This system is the only globally approved system for treatment of anatomical wastes. Among all of the available biohazardous waste treatment systems independently evaluated by Frost & Sullivan, the Ozonator system is clearly accepted as the safest and most efficient solution.

ConclusionIt is daunting to develop an efficient and sustainable biohazardous waste treatment technology. Frost & Sullivan feels that the ability to treat biohazardous waste energy efficiently and cost effectively gives the Ozonator technology a significant advantage over the other existing competing technologies. This zero-emission technology effectively addresses important industry challenges, such as lack of treatment efficiency and environmental sustainability, as well as high energy and operational costs. Hence, this technology can be considered one of the most important biohazardous waste treatment technologies for the future

S Approvals for Ozonator Technology! We have specific approval in several States of the United States of America and they are;

United States of AmericaNew YorkCalifornia

FloridaFlorida



[Type text]

South CarolinaNorth Carolina

NebraskaNorth Dakota

ColoradoMississippiMinnesota

CanadaETV Canada

Renewal NG-1000 July 2013 to 2016Ontario

Saskatchewan

InternationalSaudi Arabia

Nicaragua S.A.ColombiaMalaysia

Philippines We have the internationally recognized certification from ETV Canada and GLOBE Performance Solutions for 6 log 10 reduction. Approval for Brazil, Sweden, Romania, United Kingdom and many other locations have been granted based on the US EPA acceptance and the Canadian certification. Most developed countries recognize the California, EPA and Canadian certification.

INSTALLED OZONATOR NG-1000/ 3000 – LOCATIONS!

We have a total of 15 units installed in California, Indiana (multiple) and North Carolina. Only Union Hospital in Terre Haute, Indiana and Ozone Waste Solutions in Greensboro, North Carolina are open to visitors.



[Type text]

Current Philippines/ Malaysia Project Roll-out!

The proposal for Malaysia is for a centralized medical waste processing facility using the NG-3000 model OZONATOR where waste is brought in from several sources to be sterilized. The proposal in the Philippines is to have multiple NG-550 model OZONATOR located at strategic locations (hospitals) to process (all) waste from these facilities at source thereby reducing transport costs and liability for the movement of un-treated waste by roadway. The volume reduction of up to 90% will significantly reduce the number of truckloads of waste on highways. The first phase of the plan is to install five (5) NG-550 units in the Manila vicinity. These units will replace the current autoclave unit located at the Lung Centre Hospital in Manila. Both applications are working towards a waste to energy (WTE) plant, utilizing the treated and sterilized waste as a valuable source of fuel with a calorific value of 36.4 MJ/kg as documented by the testing results from Cardiff University in Wales. This reduces the amount of waste going to landfill by more than 95 percent. In both cases, it is necessary to review with the hospitals what types of waste are to be processed. The processing system (OZONATOR) is for medical and bio-hazard waste only. Hazardous waste must be processed in a hazardous waste stream. This would include items like radioactive waste, acids, compressed gas cylinders, flammable liquids, mercury and restricted pharmaceuticals.

Also things like titanium joints should not be placed in the waste steam for the OZONATOR NG technology due to damage to the shredder. Additionally, activated charcoal filters etc. should not be placed in the OZONATOR units.

An important note here is the ETV certifications for the OZONATOR NG technology. In the Philippines, it would have been necessary to have a unit installed in the Philippines for “proof of concept” to gain acceptance. Because we have the ETV verification, it is only necessary for the Ministry of Environment (MOE) and the Department of Science and Technology (DOST) to conduct a desk top review of the documents and testing result to approve the OZONATOR in the Philippines. We are expecting to commission our first NG-3000 in Malaysia in August and the first of several NG-550 model units in the Philippines by October. Additional units are scheduled for Sweden, California, Middle East and several other locations before year end.



[Type text]

The Southern Africa ……..

The Southern Africa Turnkey Solution!The OZONATOR NG processing system is for medical and bio-hazard waste only. Hazardous waste must be processed in a hazardous waste stream. This would include items like radioactive waste, acids, compressed gas cylinders, flammable liquids, mercury and restricted pharmaceuticals.

According South African legislation, ALL Anatomical and Pharmaceutical waste are classified hazardous waste which shall be treated by Incineration, thus Ozonator Industry ZA have procured an WHO Approved In-door Hospital Incinerator with the Global CE Standard, that generates no emissions.

Provision has also been made to deal with Mercury containing products, Aerosol Cans and Gas Canisters which will all be processed on-site!

All Ozonator Industry ZA Product Offerings provide On-site/ Off-site Solutions which is environmentally friendly emits no emissions and is cost effective! Reduced specialist packaging and long distance transportation to treatment plants based in Cape Town are eliminated! Up to 60% cost saving is currently being gained by using the Ozonator NG Technology!

Ozonator Industry ZA’s product offerings include: The supply and commissioning of all Health Care Risk Waste On-Site Treatment Plants. Renovations & alterations to on-site buildings to house the machinery! – We are registered Building

Contractors as well as Labour Department Registered Asbestos Demolition Contractors! Installation and Commissioning of machinery, Service and Maintenance Contracts for all machinery supplied. Treated waste residue disposal services! The On-site treatment of all medical and Bio-hazardous Waste – by Ozonator NG technology.

No emissions! The On-site treatment of all Anatomical and Pharmaceutical wastes including Cytotoxic and Genotoxic –

By HGH-40 (Hospital Incinerator) – No emissions!



[Type text]

Collection of all HCRW from district Clinics for processing at nearest Ozonator NG Treatment Facility utilizing the WHO Standard ClinicBOXX System!

The On-site mercury lamps/ bulbs/ medical equipment Processing – By “Big Eater” Crushing. NB. All crushed residue to be 100% Recycled, no HH Landfill! - No emissions!

On-site processing of compressed gas Cylinders and Aerosol cans. – No emissions! Vegetable Oils to be forwarded to Recycling companies for reuse – Rein Oil! Supply “Oil Spills kits” and “Blood Spill Kits”!

NB. It is recommended that all General waste, Ward and Kitchens included, be processed via the Ozonator as the treatment cost, eliminates the per Kilogram charge – it provide peace of mind that nothing infectious leaves the Hospital premises!

CURRENT WESTERN CAPE HCRWM!

Hospitals – Tertiary/ Regional & District/ Provincially Aided!

All HCRW are processed as follows:

Segregation at Institute into containers. Packaging is done at source of generation. (SANS 10228) Storage on premises – in containers & Refrigerated! Collection from premises by legally compliant Medical Waste Contractor. (SWT) Transported to Cape Town by compliant vehicles. (SANS 10229-1/ 2010) Separated at Treatment Plant Solid Waste Technologies (SWT) for treatment by EDS (Microwave –

Heat!) Pharmaceuticals and Anatomical are forwarded to BCL Incineration. Lamps & Bulbs taken/ collection by “Crush Lamp Crushing” (Included in SWT Contract -2017) Aerosol/ Gas Canister/ Mercury – processing not known!

Clinics – Non-compliant Collection of Medical Waste is practiced!

The collection of HCRW from Clinics are currently excluded from the Collection contract held by SWT, thus alternate illegal transportation to Hospitals are being practiced at great risk to those involved! The Generator’s “Duty of Care” is compromised by this action!

Packaging at source into containers. Transported to select General Hospitals by for storage and collection by SWT!

Western Cape Demographics!



[Type text]

Districts:

The Western Cape Province is divided into 5 District municipalities and 1 Metro!District Municipality Number of Municipalities Number of Hospitals Number of ClinicsCape Town Metro 1 - Metro 18 40Overberg (DC3) 4 – (WC031 - WC034) 3 4Eden (DC4) 7 – (WC041 – WC048) `7 10Central Karoo (DC5) 3 - (WC051 – WC053) 7 1Cape Winelands (DC2) 5 – (WC022 – WC026) 4 6West Coast DM (DC1) 3 – (WC011 – WC015) 7 5 /10?

Ozonator Industries ZA (Pty) Ltd has Exclusivity to the Ozonator-NG Technology for the Southern African Region which includes: South Africa/ Namibia/ Botswana/ Angola/

Zimbabwe/ Mozambique/ Swaziland / Lesotho.

Jeffrey C Block – Owner/ FounderOZONATOR INDUSTRY ZA (PTY) Ltd - Com. Reg. No. 2013/195778/07Cell: +27 71 520 0707Fax2Email: +27 86 541 8000

PO Box 887, Strand, 7139. Cape Town. South Africa.Email: [email protected]

Regular Updated Website: Environmental Expertsht t p : // www .e n viro n ment a l - ex p er t . c om / c o m p a n i es / o z o n a t o r - i n d u s t r i e s - l i mi t ed - 4 7 9 8 6

OZONATOR Industries Limited - Website: www . o z o n a t or i n d u s t ries. c o m

Western. Cape Government. Reg. No. YO0HDXKTRWMedical Research Council (MRC) Vender No.: 50002848

B-BBEE Verification Certificate No. EME/2013: A Level 1(One) Contributor

"Medical & Bio-hazardous Waste Processing by OZONE - No Emissions!"


whitepaper (final) on the benefits of ozonator ng technology

Documents

ozonator ng technology

patented ozonator technology

ozonator ng brand

technology description

heat treatment of bio

sterilization of medical

ozonator industry za

medical facilities